Nasdaq-listed firm announces $50M Hyperliquid reserve

A biotechnology company listed at Nasdaq is betting on the crypto with a move of $ 50 million in the hyperliquid media threshing token.

According to a June 17 press release Since Eyenovia, Inc., an ophthalmic technology company based in the United States, the company has obtained $ 50 million in investment capital funding to accumulate more than a million hyperliquid (THRESHING) Damn. With this decision, Eyenovia becomes the first American company listed on the stock market to hold media in its treasure and to operate as a validator of hyperliquid blockchain.

The financing agreement includes convertible favorite actions and mandates, which could collect up to $ 150 million if they are completely exercised. In addition to the announcement, Eyenovia appointed Hyunsu Jung as director of investments and member of the board of directors to supervise the new digital asset strategy.

“We are happy to join the growing number of companies adopting cryptocurrency cash strategies,” said CEO Michael Rowe. “We believe that this decision supports the assessment of long -term capital and the value of shareholders.”

Jung has called the media threshing “the most robust digital assets”, citing rapidly growth in hyperliquid and onchain’s revenues. Hype is classified as the 12th largest cryptocurrency by market capitalization, having crowded 380% of its lower April at a summit of $ 45.57 on June 16. At the time of the press, Hype is negotiated at $ 40.24, down 11% compared to its peak.

Hyperliquid, a high -speed layer 1 blockchain optimized for perpetual trading, has seen an adoption wave. In the last 30 days, it has represented 60% of the total volume of ONCHAIN ​​Perps, according to data from a dashboard of Analytics. Monthly period volume has exceeded $ 250 billion, making it a solid competitor for centralized exchanges such as Binance.

Eyenovia plans to execute an ignition strategy with its hype farms and use digital anchorage to secure its assets. In addition, the company is referred to “Hyperion Defi” and will change its symbol of Ticker in hypd.

EYENOVIA will continue to work on its flagship operative treatment system of OpteJet, which should receive the recording of the FDA by September, while turning into cryptocurrency. If other public companies follow the example of Eyenovia, hyperliquid could see a sharpness increase In the request for tokens and the effects of the network, potentially positioning it as the top 10 of the blockchain by market capitalization.